Safety and effectiveness of fecal microbiota, live-jslm (REBYOTA(®)) administered by colonoscopy for prevention of recurrent Clostridioides difficile infection: 8-week results from CDI-SCOPE, a single-arm, phase IIIb trial
通过结肠镜给予粪便微生物活体jslm(REBYOTA®)预防复发性艰难梭菌感染的安全性和有效性:一项单臂IIIb期试验CDI-SCOPE的8周结果
期刊:
影响因子:
doi:10.1177/17562848251339697
Khanna, Sahil; Yoho, David; Van Handel, Daniel; Clark, Brian J; Awad, Tahany; Guthmueller, Beth; Armandi, Daniel; Knapple, Whitfield; Safdar, Nasia; Baggott, Brian; Simon, Karen; Feuerstadt, Paul